The PRO-BNP Evaluation (PROBE) Study

Phase 2

Recruiting

• Conditions: Heart Failure; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12605000733673
• Lead Sponsor: Roche

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-11-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Admitted with clinical heart failure (Framingham criteria).

Exclusion Criteria

Unable to consent- Enrolment in other trials- Not residing locally- Acute coronary syndrome, if LVEF is >40% and/or the patient is revascularised- Severe stenotic valvular disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified